Alx Oncology Holdings Inc. (ALXO)
NASDAQ · Healthcare
Alx Oncology Holdings Inc. EBITDA 2018–2022
Alx Oncology Holdings Inc. annual/quarterly ebitda history and growth rate from 2018 to 2020. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Alx Oncology Holdings Inc. ebitda for the quarter ending June 30, 2020 was -10.7 M, a 161.36% increase year-over-year.
- Alx Oncology Holdings Inc. ebitda for the twelve months ending June 30, 2020 was -22.8 M.
- Alx Oncology Holdings Inc. annual ebitda for 2022 was -127.1 M, a 52.20% increase from 2021.
- Alx Oncology Holdings Inc. annual ebitda for 2021 was -83.5 M, a 92.14% increase from 2020.
- Alx Oncology Holdings Inc. annual ebitda for 2020 was -43.5 M, a 131.74% increase from 2019.
- Alx Oncology Holdings Inc. annual ebitda for 2019 was -18.8 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Alx Oncology Holdings Inc. EBITDA — FAQ
Alx Oncology Holdings Inc. (ALXO) ebitda over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALXO's ebitda history?
The chart and table above show Alx Oncology Holdings Inc.'s ebitda by year and by quarter, including the growth rate.